Inspire Advisors LLC Makes New Investment in Bausch Health Cos Inc. $BHC

Inspire Advisors LLC acquired a new stake in shares of Bausch Health Cos Inc. (NYSE:BHC) in the second quarter, HoldingsChannel reports. The fund acquired 71,745 shares of the company’s stock, valued at approximately $478,000.

Several other large investors also recently made changes to their positions in BHC. Universal Beteiligungs und Servicegesellschaft mbH grew its holdings in Bausch Health Cos by 10.9% in the 2nd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 64,310 shares of the company’s stock worth $428,000 after buying an additional 6,340 shares in the last quarter. Cetera Investment Advisers raised its holdings in shares of Bausch Health Cos by 73.4% in the 2nd quarter. Cetera Investment Advisers now owns 19,849 shares of the company’s stock worth $132,000 after purchasing an additional 8,402 shares in the last quarter. Creative Planning increased its holdings in shares of Bausch Health Cos by 16.9% in the second quarter. Creative Planning now owns 50,493 shares of the company’s stock valued at $336,000 after buying an additional 7,304 shares in the last quarter. SG Americas Securities LLC grew its holdings in shares of Bausch Health Cos by 114.4% in the 2nd quarter. SG Americas Securities LLC now owns 6,152,986 shares of the company’s stock worth $40,979,000 after acquiring an additional 3,282,684 shares during the last quarter. Finally, Geode Capital Management LLC raised its holdings in Bausch Health Cos by 11.2% during the 2nd quarter. Geode Capital Management LLC now owns 840,418 shares of the company’s stock worth $5,597,000 after buying an additional 84,892 shares during the period. Institutional investors and hedge funds own 78.65% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on BHC shares. Wall Street Zen raised Bausch Health Cos from a “buy” rating to a “strong-buy” rating in a research report on Saturday, November 1st. Weiss Ratings reiterated a “hold (c)” rating on shares of Bausch Health Cos in a report on Wednesday, October 8th. Three investment analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $9.00.

Bausch Health Cos Stock Down 2.2%

BHC opened at $6.05 on Thursday. Bausch Health Cos Inc. has a fifty-two week low of $4.25 and a fifty-two week high of $8.69. The company has a market capitalization of $2.24 billion, a P/E ratio of 23.25 and a beta of 0.47. The company has a debt-to-equity ratio of 141.90, a current ratio of 1.31 and a quick ratio of 0.98. The firm’s fifty day moving average price is $6.50 and its two-hundred day moving average price is $6.24.

Bausch Health Cos Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.